Biomarkers of RUNX1-RT Patients: Inherited Thrombocytipenia and Malignancy Risk
Inés Prieto Remón, Business Line Manager – Haemostasis en Sysmex Iberia shared an insightful post on LinkedIn:
”Reduced GPIa levels and impaired collagen-induced aggregation may serve as diagnostic biomarkers of RUNX1-RT patients.”
Read the article here.
Article: Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk
Authors: Ana Marín-Quílez, Ana Sánchez-Fuentes, Ana Zamora-Cánovas, Pedro Luis Gómez-González, Lorena Diaz-Ajenjo, Rocío Benito, Agustín Rodríguez-Alén, Teresa Sevivas, Thais Murciano, Laura Murillo, Nora V Butta, Nuria Revilla, Rosa Campos, Paola Escribano, Jordi Esteve, Nuria Fernández-Mosteirin, Francisca Ferrer-Marín, Laura Hernández, Jorge Huerta-Aragonés, Antonio León, Mónica López-Duarte, Eugenia López, Mónica Martín-Salces, Meritxell Nomdedeu, Raquel Oña, rene Peláez-Pleguezuelos, Fernando Ramos, Elena Sebastián, Claudia Serrano, Cristina Sierra-Aisa, Rosa Vidal-Laso, José Ramón González-Porras, María Luisa Lozano, José María Bastida, José Rivera
Stay updated on the latest scientific advances in the field of platelet disorders with Hemostasis Today.
-
Aug 13, 2025, 09:21VELORA Discover Study Now Enrolling: Advancing Care for Type 1 Von Willebrand Disease
-
Aug 13, 2025, 06:44Chokri Ben Lamine: Causes and Diagnostic Approach to PTT Prolongation
-
Aug 13, 2025, 05:41ISTH 2025 Recorded Sessions Now Available on ISTH Academy
-
Aug 13, 2025, 01:39Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
-
Aug 12, 2025, 20:03David McIntosh Urges WHO, the European Blood Alliance, the International Plasma and Fractionation Association to Stop Opposition to VRCD
-
Aug 13, 2025, 06:13Pip Nicolson: Understanding VITT From COVID-19 Vaccines
-
Aug 13, 2025, 05:23Baseline Hemoglobin Predicts Outcomes in Acute VTE: Low Hb Linked to Higher Bleeding, Ischemia and Mortality Risk
-
Aug 13, 2025, 04:13Lindsey George on Gene Therapy Transforming Hemophilia Care
-
Aug 13, 2025, 02:26Case Report Alert: Basilar Artery Occlusion in IgA-APS
-
Aug 12, 2025, 20:23Behnood Bikdeli on Comparative Effectiveness Research Examples in Thrombosis
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
-
Aug 7, 2025, 14:49JAMA+AI Conversations: David Rhew's Journey from Clinical Practice to Technology Leadership